what are the long-term side effects of semaglutide serious GLP-1 and Semaglutide: Why Smart Biomarker Monitoring Matters side – Weight-loss drugs are becoming more

These reductions indicate that intranasal GHK-Cu copper peptide not only mitigates amyloid accumulation but also potentially slows early neurodegenerative processes characteristic of AD pathology

Nausea Impacting Daily Life : If nausea affects your work, social life, or activities

Estrogen Improves Insulin Sensitivity and Suppresses Gluconeogenesis Via the Transcription Factor Foxo1

He called obesity "the number one driver of chronic disease" in the US

The study is available as open access through the link below: To view or add a comment, sign in Diabetes Conference Abstract | June 5, 2026 Using the custom Joslin Kidney Panel (JKP), an #Olink Focus 21-marker #proteomics panel developed by Olink for Joslin Diabetes Center, researchers from Harvard Medical School/Joslin Diabetes Center and Eli Lilly and Company showed that treatment with the dual GLP-1/GIP receptor agonist tirzepatide (#Mounjaro) significantly reduced circulating protein #biomarkers associated with progression to end-stage #kidney disease (#ESKD) in patients with type 2 diabetes (#T2D)